Related Experiment Video
Updated: Jul 13, 2025

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
Severe Pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children From Wild-type to Population Immunity: A
Adam J Tulling1, Gertjan Lugthart1, Miriam G Mooij2
1From the Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, the Netherlands.
Insights
Prior immunity protects children from severe COVID-19, similar to adults. Real-time data reporting influenced pediatric vaccination policies and is adaptable for future infectious disease outbreaks.
Area of Science:
- Pediatric infectious diseases
- Epidemiology
- Public Health
Background:
- SARS-CoV-2 variant evolution and increasing population immunity have changed the impact of COVID-19 in children.
- Accurate and timely clinical data reporting is crucial for informed public health decisions.
Purpose of the Study:
- To evaluate longitudinal incidence rates and risk factors for severe disease in hospitalized children with acute COVID-19 or multisystem inflammatory syndrome in children (MIS-C).
- To assess the impact of real-time data reporting on public health policies.
Main Methods:
- An international, hospital-based, multicenter prospective cohort study.
- Real-time data collection from March 2020 to December 2022.
- Inclusion of 564 hospitalized children with acute COVID-19 or MIS-C.
Main Results:
- Among 375 children with acute COVID-19, 36% required supplemental oxygen and 9.3% needed intensive care. Predictors for severe COVID-19 included age over 12 and pre-existing pulmonary conditions.
- Hospitalized children experienced milder disease during the Omicron wave.
- The incidence of MIS-C peaked during the Delta wave and declined with Omicron's emergence. Pediatric COVID-19 incidence decreased in older children but remained stable in infants.
- Real-time data reporting informed national pediatric SARS-CoV-2 vaccination and booster policies.
Conclusions:
- Prior immunity, similar to adults, confers protection against severe SARS-CoV-2 sequelae in children.
- Real-time, high-quality data reporting is feasible and significantly impacts clinical and public health decision-making.
- The established reporting framework can be utilized for future SARS-CoV-2 waves and other emerging infectious diseases.
Background:
SARS-CoV-2 variant evolution and increasing immunity altered the impact of pediatric SARS-CoV-2 infection. Public health decision-making relies on accurate and timely reporting of clinical data.
Methods:
This international hospital-based multicenter, prospective cohort study with real-time reporting was active from March 2020 to December 2022. We evaluated longitudinal incident rates and risk factors for disease severity.
Results:
We included 564 hospitalized children with acute COVID-19 (n = 375) or multisystem inflammatory syndrome in children (n = 189) from the Netherlands, Curaçao and Surinam. In COVID-19, 134/375 patients (36%) needed supplemental oxygen therapy and 35 (9.3%) required intensive care treatment. Age above 12 years and preexisting pulmonary conditions were predictors for severe COVID-19. During omicron, hospitalized children had milder disease. During population immunity, the incidence rate of pediatric COVID-19 infection declined for older children but was stable for children below 1 year. The incidence rate of multisystem inflammatory syndrome in children was highest during the delta wave and has decreased rapidly since omicron emerged. Real-time reporting of our data impacted national pediatric SARS-CoV-2 vaccination- and booster-policies.
Conclusions:
Our data supports the notion that similar to adults, prior immunity protects against severe sequelae of SARS-CoV-2 infections in children. Real-time reporting of accurate and high-quality data is feasible and impacts clinical and public health decision-making. The reporting framework of our consortium is readily accessible for future SARS-CoV-2 waves and other emerging infections.
Related Concept Videos
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History

